The Journal of Heart and Lung Transplantation
Volume 21, Issue 2 , Pages 251-259 , February 2002

Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors

This manuscript was presented at the Transplant 2000 meeting at the Chicago Sheraton Hotel, May 13–17, 2000.

  • Shi-Ping Luh, MD, PhD

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Chen-Cheng Tsai, MD

      Affiliations

    • Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Wen-Yi Shau, MD

      Affiliations

    • Institute of Clinical Research, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Shoei-Yn Lin Shiau, PhD

      Affiliations

    • Pharmacology and Toxicology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • I-Shiow Jan, MD

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Sow-Hsong Kuo, MD

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Pan-Chyr Yang, MD, PhD

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
    • Corresponding Author InformationReprint requests: Pan-Chyr Yang, Department of Medicine, National Taiwan University Hospital. Room 14 to 05, 7 Chun-Shan S Rd, Taipei, Taiwan, Republic of China. Telephone: +011-8862-23123456, ext 2116

Received 19 January 2001 ,Accepted 27 June 2001.

References 

  1. Egan TM, Lambert C, Reddick R, Ulicny K, Keagy BA, Wilcox BR. A strategy to increase the donor pool (use of cadaver lungs for transplantation). Ann Thorac Surg. 1991;52:1113–1121
  2. Ulicny K, Egan TM, Lambert C, Wilcox BR. Cadaver lung donors (effect of preharvest ventilation on graft function). Ann Thorac Surg. 1993;55:1185–1191
  3. Murakami S, Bacha EA, Herve P, et al.  Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors. Ann Thorac Surg. 1996;62:1632–1638
  4. Luh SP, Tsai CC, Shau WY, et al.  The effects of inhaled nitric oxide, gabexate mesilate (FOY), and retrograde flush in the lung graft from non-heart-beating minipig donors. Transplantation. 2000;69(10):
  5. Akashi A, Nakahara K, Kamiike W, et al.  Attenuation of warm ischemic injury of rat lung by inflation with room air-assessment of cellular components and the surfactant in the bronchoalveolar lavage fluid in relation to changes in celluar adenosine triphosphate. Transplantation. 1993;55:24–30
  6. Kuo PC, Schroeder RA. The emerging multifaceted roles of nitric oxide. Ann Surg. 1995;221:220–225
  7. Murakami K, Okajima K, Uchiba M, Okabe H, Takatsuki K. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes. Crit Care Med. 1996;24:1047–1053
  8. Luh SP, Tsai CC, Shau WY, et al.  Effects of Gabexate mesilate (FOY) on ischemia-reperfusion induced acute lung injury in dogs. J Surg Res. 1999;87:152–163
  9. Niehaus GD, Kimura R, Traber LD, et al.  Administration of a synthetic antiprotease reduces smoke induced injury. J Appl Physiol. 1990;69:694–699
  10. Matsumura A, Nakahara K, Miyoshi S, Mizuta T, Akashi A, Kawashima Y. Filtration coefficient in isolated preservation in a rabbit model. J Thorac Cardiovasc Surg. 1991;101:1037–1043
  11. Nakayama M, Hasegawa M, Oka Y, et al.  Effects of the lazaroid, titrilazad mesylate, on sepsis-induced acute lung injury in minipigs. Crit Care Med. 1998;26:538–547
  12. Nishing K. Inhaled nitric oxide does not prevent endotoxin induced lung injury in rabbits. Ann Anes Scand. 1997;41:399–407
  13. Friedman M, Silike FW, Steven Y, et al.  Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90(suppl):II262–II268
  14. Seibert AF, Haynes J, Taylor A. Ischemia-reperfusion injury in the isolated rat lung, role of flow and endogenous leukocytes. Am Rev Respir Dis. 1993;147:270–275
  15. Goldlum SE, Wu K, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1985;59:1978–1985
  16. Kraiwsz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in ratand hamster models. Gastroenterology. 1984;87:1344–1350
  17. Lechner JF, Stoner GD, Yoakum GH, et al.  In vitro carcinogenesis studies with human tracheobronchial tissues and cells. In:  Schiff LJ editors. In vitro models of respiratory epithelium. Boca Raton, FL: CRC Press; 1986;p. 447
  18. D’Armini AM, Roberts CS, Griffith PK, Lemasters JJ, Egan TM. When does the lung die? I. Histological evidence of pulmonary viability after “death.”. J Heart Lung Transplant. 1994;13:741–747
  19. Alessandrini F, D’Armini AM, Robberts CS, Reddick RL, Egan TM. When does the lung die? II Ultrastructural evidence of pulmonary viability after death. J Heart Lung Transplant. 1994;13:748–757
  20. Kishima H, Takeda SI, Miyoshi S, et al.  Microvascular permeability of the non-heart-beating rabbit lung after warm ischemia and reperfusion (role of neutrophil elastase). Ann Thorac Surg. 1998;65:913–918
  21. Modry DL, Warnecke H, Walpoth BW, et al.  Heart-lung preservation followed by lung transplantation (a new model for the assessment of lung preservation). J Heart Transplant. 1983;2:287–298
  22. Wang LS, Yoshikawa K, Miyoshi S, et al.  The effect of ischemic time and temperature on lung preservation in a simple ex vivo model used for functional assessment. J Thorac Cardiovasc Surg. 1989;98:333–342
  23. Ross CA, Alves RF. Preservation of canine lung for reimplantation using hypothermia and hyperbaric oxygen. Thorax. 1969;24:336–341
  24. Veith FJ, Kamholz SL, Mollenkopf FP. Lung transplantation. Transplantation. 1983;35:271–278
  25. Matsumura A, Nakahara K, Miyoshi S, Mizuta T, Akashi A, Kawashima Y. Filtration coefficient in isolated preserved and reperfused canine lung. J Surg Res. 1991;50:205–211
  26. Pederzoli P, Cavallini G, Falconi M, et al.  Gabexate mesilate versus aprotinin in human acute pancreatitis. Int J Pancreatol. 1993;14:117–120
  27. Taenaka N, Shimada Y, Hirata T, et al.  Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med. 1983;11:735–740
  28. Nishijima J, Hiraoka N, Murata A, et al.  Protease inhibitors (gabexate mesilate and ulnastatin) inhibit intracellular chemiluminescence in human neutrophils. J Leukocyte Biol. 1992;52:262–267
  29. Tamura K, Manabe T, Imanishi K, et al.  Effect of synthetic protease inhibitors on superoxide, hydrogen peroxide, and hydroxyl radical production by human polymorphonuclear leukocytes. Hepato Gastroenterol. 1992;39:59–63
  30. Mikawa K, Akamatsu H, Maekawa N, et al.  Inhibitory effects of gabexate mesilate on human neutrophil function. J Intern Med Res. 1994;22:245–251
  31. Singh S, Evans TW. Nitric oxide, the biological mediator of the decade (fact or fiction?). Eur Respir J. 1997;10:699–707
  32. Cooke JP, Tsao PS. Cytoprotective effect of nitric oxide. Circulation. 1993;88:2451–2454
  33. Kubes P, Suzuki M, Granger DN. Nitric oxide (an endogenous modulator of leukocyte adhesion). Proc Natl Acad Sci USA. 1995;88:4651–4654
  34. Bacha EA, Sellak H, Murakami S, et al.  Inhaled nitric oxide attenuates reperfusion injury in non-heart-beating donor lung transplantation. Transplantation. 1997;63:1380–1386
  35. Lindberg L, Sjoberg T, Ingemansson R, Steen S. Inhalation of nitric oxide after lung transplantation. Ann Thorac Surg. 1996;61:956–962

PII: S1053-2498(01)00368-0

The Journal of Heart and Lung Transplantation
Volume 21, Issue 2 , Pages 251-259 , February 2002

Article Tools

* Image Usage & Resolution